BIOMAT Database Logo BIOMAT Database Logo

Lipoprotein(a) levels and fibrinolytic activity in patients with nephrotic syndrome. 1996

A Segarra, and P Chacón, and L L Piera

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009404 Nephrotic Syndrome A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction. Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D017270 Lipoprotein(a) A lipoprotein that resembles the LOW-DENSITY LIPOPROTEINS but with an extra protein moiety, APOPROTEIN (A) also known as APOLIPOPROTEIN (A), linked to APOLIPOPROTEIN B-100 on the LDL by one or two disulfide bonds. High plasma level of lipoprotein (a) is associated with increased risk of atherosclerotic cardiovascular disease. Lipoprotein (a),Lipoprotein (a-),Lipoprotein Lp(a),Lipoprotein a

Related Publications

A Segarra, and P Chacón, and L L Piera
Lipoprotein(a) levels and fibrinolytic activity in patients with nephrotic syndrome.
January 1995, Nephron,
A Segarra, and P Chacón, and L L Piera
Plasma lipoprotein(a) levels and fibrinolytic activity in patients with unstable angina.
October 1993, Japanese circulation journal,
A Segarra, and P Chacón, and L L Piera
[Fibrinolytic system in patients with nephrotic syndrome].
January 1976, Terapevticheskii arkhiv,
A Segarra, and P Chacón, and L L Piera
Lipoprotein(a) levels in the nephrotic syndrome.
January 1994, Annals of internal medicine,
A Segarra, and P Chacón, and L L Piera
Lipoprotein(a) levels in the nephrotic syndrome.
August 1992, Internal medicine (Tokyo, Japan),
A Segarra, and P Chacón, and L L Piera
[Fibrinolytic and lipid disturbances in patients with nephrotic syndrome].
November 1994, Polskie Archiwum Medycyny Wewnetrznej,
A Segarra, and P Chacón, and L L Piera
Elevated lipoprotein (a) levels in primary nephrotic syndrome.
December 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation,
A Segarra, and P Chacón, and L L Piera
Low density lipoprotein levels in children with nephrotic syndrome.
April 1976, Indian pediatrics,
A Segarra, and P Chacón, and L L Piera
Serum remnant lipoprotein levels in nephrotic syndrome.
March 2001, Clinical nephrology,
A Segarra, and P Chacón, and L L Piera
Influence of lipoprotein (a) levels and isoforms on fibrinolytic activity--study in families with high lipoprotein (a) levels.
April 1998, Thrombosis and haemostasis,
Copied contents to your clipboard!